Technical Analysis for CPHI - China Pharma Holdings, Inc.

Grade Last Price % Change Price Change
D 0.66 -3.65% -0.03
CPHI closed down 3.65 percent on Friday, April 16, 2021, on 21 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical CPHI trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion -3.65%
Below Lower BB Weakness -3.65%
Older End-of-Day Signals for CPHI ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 9 hours ago
60 Minute Opening Range Breakdown about 9 hours ago
Down 3% about 9 hours ago
Fell Below Previous Day's Low about 9 hours ago
Rose Above Lower Bollinger Band about 10 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


China Pharma Holdings, Inc. Description

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. It offers products in the form of dry powder injectibles, liquid injectibles, tablets, capsules, oral solutions, and granules. The company's products are used for the treatment of central nervous system and cerebral cardiovascular, anti-infection and respiratory, and digestive and other diseases. Its products include Bumetanide to treat edema diseases; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Buflomedil Hydrochloride for blood vessel diseases; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and surgery-thrombus deep phlebitis; and Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and lipoprotein blood diseases. The company also provides Cefaclor Dispersible tablets for tympanitis, lower respiratory tract infection; Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Clarithromycin granules and capsules for nasopharynx, respiratory tract, and skin tissue infections; Naproxen Sodium and Pseudophedrine Hydrochloride Sustained Release tablets to relieve cold, sinus, and flu symptoms; Cefalexin capsules for acute tonsillitis; and Anhydroandrographolide for ischemic heart, cerebrovascular, and lipoprotein blood diseases. In addition, it offers Hepatocyte growth-promoting factor; Tiopronin; Omeprazole; Granisetron Hydrochloride injection; Vitamin B6; and Gull Wood extract syrup, as well as Recombined Human Fibroblast Growth Factor products for the repair of wounded skin cells. The company distributes its products through independent regional distributors and sales representatives. China Pharma Holdings, Inc. is based in Haikou, the People's Republic of China.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Surgery Chemical Product Pharmacology Chemical Products Chloride Vitamin Symptoms Wound Syndromes Syrup Attention Deficit Lipoprotein Sinus Fibroblast Growth Factor Heart Disease Thrombosis Tablet Blood Diseases Growth Factor Products Lower Respiratory Tract Infection Respiratory Tract Respiratory Tract Infection Thrombus

Is CPHI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 1.63
52 Week Low 0.32
Average Volume 2,934,378
200-Day Moving Average 0.60
50-Day Moving Average 0.95
20-Day Moving Average 0.89
10-Day Moving Average 0.85
Average True Range 0.12
ADX 25.73
+DI 30.59
-DI 28.23
Chandelier Exit (Long, 3 ATRs ) 1.28
Chandelier Exit (Short, 3 ATRs ) 1.00
Upper Bollinger Band 1.11
Lower Bollinger Band 0.67
Percent B (%b) -0.03
BandWidth 48.96
MACD Line -0.05
MACD Signal Line -0.02
MACD Histogram -0.0301
Fundamentals Value
Market Cap 28.76 Million
Num Shares 43.6 Million
EPS -0.25
Price-to-Earnings (P/E) Ratio -2.68
Price-to-Sales 2.12
Price-to-Book 2.96
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.73
Resistance 3 (R3) 0.73 0.71 0.71
Resistance 2 (R2) 0.71 0.69 0.71 0.71
Resistance 1 (R1) 0.68 0.68 0.67 0.68 0.71
Pivot Point 0.66 0.66 0.66 0.66 0.66
Support 1 (S1) 0.64 0.65 0.63 0.64 0.61
Support 2 (S2) 0.62 0.64 0.62 0.61
Support 3 (S3) 0.60 0.62 0.61
Support 4 (S4) 0.59